16912578

Source:http://linkedlifedata.com/resource/pubmed/id/16912578

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008972, umls-concept:C0026705, umls-concept:C0205390, umls-concept:C0598391, umls-concept:C1739462
pubmed:issue	8
pubmed:dateCreated	2006-8-16
pubmed:abstractText	To evaluate the safety and efficacy of recombinant human iduronate-2-sulfatase (idursulfase) in the treatment of mucopolysaccharidosis II.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/FD-R-002565-0, http://linkedlifedata.com/resource/pubmed/grant/M01-RR00036, http://linkedlifedata.com/resource/pubmed/grant/M01-RR00188, http://linkedlifedata.com/resource/pubmed/grant/M01-RR01272, http://linkedlifedata.com/resource/pubmed/grant/RR00046
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16912578
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9815831
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/IDS protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Iduronate Sulfatase, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1098-3600
pubmed:author	pubmed-author:BeckMichaelM, pubmed-author:ClearyMaureenM, pubmed-author:ConwayAnn MarieAM, pubmed-author:ConwayAnne MarieAM, pubmed-author:EngChristine MCM, pubmed-author:GiuglianiRobertoR, pubmed-author:Gucsavas-CalikogluMugeM, pubmed-author:HarmatzPaulP, pubmed-author:KimuraAlanA, pubmed-author:MartinRickR, pubmed-author:MuenzerJosephJ, pubmed-author:PiperDianeD, pubmed-author:PugaAna CristinaAC, pubmed-author:PugaAntonioA, pubmed-author:RamaswamiUmaU, pubmed-author:ShinawiMarwanM, pubmed-author:UlbrichBrianB, pubmed-author:VellodiAshokA, pubmed-author:VijayaraghavanSureshS, pubmed-author:WendtSusanneS, pubmed-author:WendtSuzanneS, pubmed-author:WraithJames EJE
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	465-73
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16912578-Adolescent, pubmed-meshheading:16912578-Adult, pubmed-meshheading:16912578-Child, pubmed-meshheading:16912578-Child, Preschool, pubmed-meshheading:16912578-Double-Blind Method, pubmed-meshheading:16912578-Drug Tolerance, pubmed-meshheading:16912578-Glycoproteins, pubmed-meshheading:16912578-Humans, pubmed-meshheading:16912578-Iduronate Sulfatase, pubmed-meshheading:16912578-Male, pubmed-meshheading:16912578-Mucopolysaccharidosis II, pubmed-meshheading:16912578-Recombinant Proteins, pubmed-meshheading:16912578-Safety, pubmed-meshheading:16912578-Vital Capacity
pubmed:year	2006
pubmed:articleTitle	A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome).
pubmed:affiliation	University of North Carolina, Department of Pediatrics, Chapel Hill, NC 27599, USA.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Clinical Trial, Phase II, Clinical Trial, Phase III, Research Support, N.I.H., Extramural